Elysium Health, Inc. Loses Appeal of Patent Challenge Decision, Upholding Validity of ChromaDex Intellectual Property

LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC) issued the following statement: Given recently announced court closures and other restrictions due to the COVID-19 pandemic, the company would like to take this opportunity to provide an update on the ongoing litigation with Elysium Health. In March, the Court of Appeals for the Federal Circuit (?Federal Circuit?) rejected Elysium?s challenge to the validity of U.S. Patent No. 8,383,086 (?the ?086 patent?), upholding the decision of th

Click to view original post